Sun Pharmaceutical Industries Limited (524715,SUNPHARMA), a major Indian pharmaceutical company, on Friday reported a rise in earnings and revenue for the final quarter of fiscal 2026.
For the three-month period to March 31, the company posted a net profit of INR 27.140 billion, higher than INR 21.498 billion in the same period last year. Net income was INR 11.3 per share as against the prior year's INR 9 per share. Revenue was INR 146.117 billion, up from INR 129.588 billion in the previous year.
For the full year, the Board will pay a final dividend of INR 5 per share, which will bring the total dividend for the year to INR 16 per share, unchanged from last year's INR 16 per share.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.